NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

特殊醫藥品流通市場調查報告:各適應症,各類型,各流通類型,各流通管道-2025年前的預測-COVID-19累積的影響

Specialty Drug Distribution Market Research Report by Indication, by Type, by Distribution Type, by Distribution Channel, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1002736
出版日期 內容資訊 英文 194 Pages
商品交期: 最快1-2個工作天內
價格
特殊醫藥品流通市場調查報告:各適應症,各類型,各流通類型,各流通管道-2025年前的預測-COVID-19累積的影響 Specialty Drug Distribution Market Research Report by Indication, by Type, by Distribution Type, by Distribution Channel, by Region - Global Forecast to 2025 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 194 Pages
簡介

全球特殊醫藥品流通的市場規模預測將從2020年的15億8,844萬美元,擴大到2025年的30億5,388萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供特殊醫藥品流通市場相關調查,提供市場概要,以及各適應症,各類型,各流通類型,各流通管道,各地區的趨勢,COVID-19累積的影響,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和範圍
  • 調查對象年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃作成
    • 實行:調查實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 各流通類型預測
  • 各類型預測
  • 各適應症預測
  • 各流通管道預測
  • 各地區預測
  • 其他競爭公司預測

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特五力分析
    • 新加入廠商業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 全球特殊醫藥品流通市場,各適應症

  • AIDS
  • 血友病
  • 多發性硬化症
  • 腫瘤學
  • 類風濕性關節炎

第7章 全球特殊醫藥品流通市場,各類型

  • 全產品線批發商
  • 特殊醫藥品經銷商

第8章 全球特殊醫藥品流通市場,各流通類型

  • 診所/ASC
  • 家庭的健康
  • 住院患者
  • 郵遞員
  • 門診病人
  • 零售

第9章 全球特殊醫藥品流通市場,各流通管道

  • 醫院及照護供應商
  • 獨立型藥局
  • 大規模連鎖藥局
  • 網路商店
  • 專門藥局

第10章 南北美洲的特殊醫藥品流通市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區的特殊醫藥品流通市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第12章 歐洲,中東·非洲的特殊醫藥品流通市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第13章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 競爭模式
    • 合併和收購
    • 契約,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第14章 企業的實用性簡介

  • Alliance Healthcare
  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • CVS Health Corporation
  • Diplomat Pharmacy, Inc.
  • Express Scripts Holding Company
  • McKesson Corporation
  • Mediceo Paltac Holdings Co., Ltd.
  • Pfizer Inc.
  • Shanghai Pharma
  • Sinopharm
  • Smith Drug Co., Inc.

第15章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-43192CEFCC36

The Global Specialty Drug Distribution Market size was estimated at USD 1,588.44 Million in 2020 and expected to reach USD 1,807.37 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.96% to reach USD 3,053.88 Million by 2025.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2025 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Specialty Drug Distribution to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Indication, the Specialty Drug Distribution Market was studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis.

Based on Type, the Specialty Drug Distribution Market was studied across Full line Wholesalers and Specialty Distributors.

Based on Distribution Type, the Specialty Drug Distribution Market was studied across Clinic/ASCs, Home Health, Inpatient, Mail Delivery, Outpatient, and Retail.

Based on Distribution Channel, the Specialty Drug Distribution Market was studied across Hospitals & Care Providers, Independent Pharmacies, Large Chain Pharmacies, Online Stores, and Specialty Pharmacies.

Based on Geography, the Specialty Drug Distribution Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Specialty Drug Distribution Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Specialty Drug Distribution Market, including Alliance Healthcare, AmerisourceBergen Corporation, Cardinal Health, Inc., CuraScript, Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., Express Scripts Holding Company, McKesson Corporation, Mediceo Paltac Holdings Co., Ltd., Pfizer Inc., Shanghai Pharma, Sinopharm, and Smith Drug Co., Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Specialty Drug Distribution Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Specialty Drug Distribution Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Specialty Drug Distribution Market?
  • 4. What is the competitive strategic window for opportunities in the Global Specialty Drug Distribution Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Specialty Drug Distribution Market?
  • 6. What is the market share of the leading vendors in the Global Specialty Drug Distribution Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Specialty Drug Distribution Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Distribution Type Outlook
  • 3.4. Type Outlook
  • 3.5. Indication Outlook
  • 3.6. Distribution Channel Outlook
  • 3.7. Geography Outlook
  • 3.8. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Demand and Significance of Hepatitis, Cancer, and Multiple Sclerosis Drug Globally
      • 5.1.1.2. Prevalence of Complex Chronic Condition
      • 5.1.1.3. Need for Extensive Reach and Fast Shipping
      • 5.1.1.4. Government Support for Drug Development for Serious or Life-Threatening Disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Steep Prices of the Drugs
      • 5.1.2.2. Limited Reimbursement Options
    • 5.1.3. Opportunities
      • 5.1.3.1. Patient Assistance Programs to Help Patients Afford their Treatments
      • 5.1.3.2. Cold Chain Management for Temperature Monitoring and Sophisticated Environment System
    • 5.1.4. Challenges
      • 5.1.4.1. Changing Regulatory Framework
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Specialty Drug Distribution Market, by Indication

  • 6.1. Introduction
  • 6.2. AIDS
  • 6.3. Hemophilia
  • 6.4. Multiple Sclerosis
  • 6.5. Oncology
  • 6.6. Rheumatoid Arthritis

7. Specialty Drug Distribution Market, by Type

  • 7.1. Introduction
  • 7.2. Full line Wholesalers
  • 7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Distribution Type

  • 8.1. Introduction
  • 8.2. Clinic/ASCs
  • 8.3. Home Health
  • 8.4. Inpatient
  • 8.5. Mail Delivery
  • 8.6. Outpatient
  • 8.7. Retail

9. Specialty Drug Distribution Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Care Providers
  • 9.3. Independent Pharmacies
  • 9.4. Large Chain Pharmacies
  • 9.5. Online Stores
  • 9.6. Specialty Pharmacies

10. Americas Specialty Drug Distribution Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Specialty Drug Distribution Market

  • 11.1. Introduction
  • 11.2. China
  • 11.3. India
  • 11.4. Indonesia
  • 11.5. Japan
  • 11.6. Malaysia
  • 11.7. Philippines
  • 11.8. South Korea
  • 11.9. Thailand

12. Europe, Middle East & Africa Specialty Drug Distribution Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Quadrant
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Alliance Healthcare
  • 14.2. AmerisourceBergen Corporation
  • 14.3. Cardinal Health, Inc.
  • 14.4. CuraScript, Inc.
  • 14.5. CVS Health Corporation
  • 14.6. Diplomat Pharmacy, Inc.
  • 14.7. Express Scripts Holding Company
  • 14.8. McKesson Corporation
  • 14.9. Mediceo Paltac Holdings Co., Ltd.
  • 14.10. Pfizer Inc.
  • 14.11. Shanghai Pharma
  • 14.12. Sinopharm
  • 14.13. Smith Drug Co., Inc.

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
  • 15.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 2. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: MARKET DYNAMICS
  • FIGURE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
  • FIGURE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2025
  • FIGURE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, 2018-2025 (USD MILLION)
  • FIGURE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, 2018-2025 (USD MILLION)
  • FIGURE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2025 (USD MILLION)
  • FIGURE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, 2018-2025 (USD MILLION)
  • FIGURE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2018-2025 (USD MILLION)
  • FIGURE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
  • FIGURE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2025
  • FIGURE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, 2018-2025 (USD MILLION)
  • FIGURE 26. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, 2018-2025 (USD MILLION)
  • FIGURE 28. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 VS 2025 (%)
  • FIGURE 30. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2025
  • FIGURE 32. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, 2018-2025 (USD MILLION)
  • FIGURE 33. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, 2018-2025 (USD MILLION)
  • FIGURE 35. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, 2018-2025 (USD MILLION)
  • FIGURE 37. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 38. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, 2018-2025 (USD MILLION)
  • FIGURE 39. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 40. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, 2018-2025 (USD MILLION)
  • FIGURE 41. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 42. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, 2018-2025 (USD MILLION)
  • FIGURE 43. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 44. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (%)
  • FIGURE 45. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2025 (USD MILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
  • FIGURE 47. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, 2018-2025 (USD MILLION)
  • FIGURE 48. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 49. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, 2018-2025 (USD MILLION)
  • FIGURE 50. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 51. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, 2018-2025 (USD MILLION)
  • FIGURE 52. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 53. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, 2018-2025 (USD MILLION)
  • FIGURE 54. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 55. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2025 (USD MILLION)
  • FIGURE 56. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 57. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 58. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 60. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 66. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 68. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 72. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 73. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 74. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 75. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 76. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 77. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 79. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 80. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 81. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 82. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 83. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 84. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 85. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 86. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 87. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 88. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 89. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 90. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: FPNV POSITIONING MATRIX
  • FIGURE 91. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 92. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY CLINIC/ASCS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME HEALTH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INPATIENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY OUTPATIENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RETAIL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. RUSSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. SAUDI ARABIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. SOUTH AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. SPAIN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. UNITED ARAB EMIRATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. UNITED KINGDOM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: SCORES
  • TABLE 137. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: BUSINESS STRATEGY
  • TABLE 138. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: PRODUCT SATISFACTION
  • TABLE 139. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: RANKING
  • TABLE 140. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 141. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: MERGER & ACQUISITION
  • TABLE 142. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 143. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 144. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: INVESTMENT & FUNDING
  • TABLE 145. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 146. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: LICENSE & PRICING
  • TABLE 147. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET: CONTACT DETAILS